• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎中破骨细胞相关受体(一种关键的破骨细胞共刺激分子)的诱导作用

Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis.

作者信息

Herman Sonja, Müller Ruediger B, Krönke Gerhard, Zwerina Jochen, Redlich Kurt, Hueber Axel J, Gelse Holger, Neumann Elena, Müller-Ladner Ulf, Schett Georg

机构信息

Department of Internal Medicine III, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany.

出版信息

Arthritis Rheum. 2008 Oct;58(10):3041-50. doi: 10.1002/art.23943.

DOI:10.1002/art.23943
PMID:18821671
Abstract

OBJECTIVE

Osteoclast-associated receptor (OSCAR) is a newly identified osteoclast-specific receptor and is of key importance in the process of osteoclast costimulation. This study was undertaken to define the role of costimulation in osteoclast differentiation during inflammatory arthritis.

METHODS

OSCAR expression was assessed in the synovium and peripheral blood monocytes of patients with rheumatoid arthritis (RA), and associations with disease activity were assessed. Serum levels of OSCAR were determined by enzyme-linked immunosorbent assay. In vitro osteoclast assays were performed to characterize the role of OSCAR in human osteoclastogenesis. Cytokine regulation of OSCAR was investigated by reverse transcriptase-polymerase chain reaction.

RESULTS

OSCAR was expressed by osteoclasts at the erosion front and by mononuclear cells around synovial microvessels. Flow cytometry revealed enhanced expression of OSCAR in peripheral blood monocytes of RA patients as compared with healthy controls. OSCAR expression was correlated with disease activity and acute-phase reactant concentrations. Serum levels of soluble OSCAR were lower in RA patients than in healthy controls. Monocytes with high OSCAR expression exhibited an enhanced potential to differentiate into osteoclasts. Tumor necrosis factor alpha was identified as the main inducer of OSCAR expression in monocytes.

CONCLUSION

These data suggest that the osteoclast costimulation pathway is activated in RA. OSCAR is induced in monocytes of RA patients, facilitating their differentiation into osteoclasts and bone resorption.

摘要

目的

破骨细胞相关受体(OSCAR)是一种新发现的破骨细胞特异性受体,在破骨细胞共刺激过程中起关键作用。本研究旨在确定共刺激在炎性关节炎破骨细胞分化过程中的作用。

方法

评估类风湿关节炎(RA)患者滑膜和外周血单核细胞中OSCAR的表达,并评估其与疾病活动度的相关性。采用酶联免疫吸附测定法测定血清OSCAR水平。进行体外破骨细胞试验以表征OSCAR在人破骨细胞生成中的作用。通过逆转录聚合酶链反应研究细胞因子对OSCAR的调节作用。

结果

破骨细胞在侵蚀前沿表达OSCAR,滑膜微血管周围的单核细胞也表达OSCAR。流式细胞术显示,与健康对照相比,RA患者外周血单核细胞中OSCAR表达增强。OSCAR表达与疾病活动度和急性期反应物浓度相关。RA患者血清可溶性OSCAR水平低于健康对照。高表达OSCAR的单核细胞分化为破骨细胞的潜力增强。肿瘤坏死因子α被确定为单核细胞中OSCAR表达的主要诱导因子。

结论

这些数据表明,RA中破骨细胞共刺激途径被激活。RA患者单核细胞中诱导产生OSCAR,促进其分化为破骨细胞并导致骨吸收。

相似文献

1
Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis.类风湿关节炎中破骨细胞相关受体(一种关键的破骨细胞共刺激分子)的诱导作用
Arthritis Rheum. 2008 Oct;58(10):3041-50. doi: 10.1002/art.23943.
2
CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.趋化因子CXCL12上调人破骨细胞的骨吸收及基质金属蛋白酶-9的释放:类风湿性关节炎患者滑膜和骨组织中CXCL12水平升高。
J Cell Physiol. 2004 May;199(2):244-51. doi: 10.1002/jcp.10445.
3
Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.破骨细胞前体与类风湿性滑膜成纤维细胞共培养通过转化生长因子β介导的骨保护素下调诱导破骨细胞生成。
Arthritis Rheum. 2008 Nov;58(11):3356-65. doi: 10.1002/art.23971.
4
The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the In Vitro Osteoclast Differentiation in Arthritis (IODA) study.类风湿关节炎患者体外破骨细胞生成增加是由于前体细胞百分比增加和凋亡减少所致——关节炎体外破骨细胞分化(IODA)研究。
Bone. 2011 Mar 1;48(3):588-96. doi: 10.1016/j.bone.2010.10.167. Epub 2010 Oct 17.
5
LIGHT up-regulated on B lymphocytes and monocytes in rheumatoid arthritis mediates cellular adhesion and metalloproteinase production by synoviocytes.在类风湿性关节炎中,LIGHT在B淋巴细胞和单核细胞上上调,介导滑膜细胞的细胞黏附及金属蛋白酶生成。
Arthritis Rheum. 2007 Apr;56(4):1106-17. doi: 10.1002/art.22493.
6
Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation.人类风湿性滑膜成纤维细胞通过TLR - 2和TLR - 4激活来激活RANKL,从而促进破骨细胞生成活性。
Immunol Lett. 2007 May 15;110(1):54-64. doi: 10.1016/j.imlet.2007.03.004. Epub 2007 Apr 17.
7
Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes.早期类风湿关节炎患者的外周血T淋巴细胞在细胞表面表达核因子κB受体活化因子配体(RANKL)和白细胞介素-15,并促进自体单核细胞的破骨细胞生成。
Arthritis Rheum. 2006 Apr;54(4):1151-64. doi: 10.1002/art.21731.
8
Rheumatoid synovial endothelial cells produce macrophage colony-stimulating factor leading to osteoclastogenesis in rheumatoid arthritis.类风湿性滑膜内皮细胞产生巨噬细胞集落刺激因子,导致类风湿性关节炎中的破骨细胞生成。
Rheumatology (Oxford). 2007 Apr;46(4):597-603. doi: 10.1093/rheumatology/kel356. Epub 2006 Oct 24.
9
Osteoclast-Associated Receptor (OSCAR) Distribution in the Synovial Tissues of Patients with Active RA and TNF-α and RANKL Regulation of Expression by Osteoclasts In Vitro.破骨细胞相关受体 (OSCAR) 在活动期 RA 患者滑膜组织中的分布,以及破骨细胞体外对 TNF-α 和 RANKL 表达的调控。
Inflammation. 2017 Oct;40(5):1566-1575. doi: 10.1007/s10753-017-0597-2.
10
Changes in serum levels of soluble osteoclast-associated receptor in human rheumatoid arthritis.血清可溶性破骨细胞相关受体水平在人类类风湿关节炎中的变化。
Chin Med J (Engl). 2011 Oct;124(19):3058-60.

引用本文的文献

1
Nucleic acid aptamers in orthopedic diseases: promising therapeutic agents for bone disorders.骨科疾病中的核酸适配体:治疗骨病的潜在治疗剂。
Bone Res. 2025 Jul 24;13(1):71. doi: 10.1038/s41413-025-00447-8.
2
Osteoclast Activation and Inflammatory Bone Diseases: Focusing on Receptors in Osteoclasts.破骨细胞激活与炎症性骨疾病:聚焦破骨细胞中的受体
J Inflamm Res. 2025 Mar 4;18:3201-3213. doi: 10.2147/JIR.S507269. eCollection 2025.
3
Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated Review.类风湿关节炎和脊柱关节炎中的骨骼受累:最新综述
Biology (Basel). 2023 Oct 9;12(10):1320. doi: 10.3390/biology12101320.
4
The emerging studies on mesenchymal progenitors in the long bone.关于长骨中间充质祖细胞的新兴研究。
Cell Biosci. 2023 Jun 10;13(1):105. doi: 10.1186/s13578-023-01039-x.
5
Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast CNCM I-745 reduces bone loss in osteoporosis.益生菌酵母 CNCM I-745 通过特异性靶向炎症性破骨细胞生成,减少骨质疏松症中的骨丢失。
Elife. 2023 Feb 27;12:e82037. doi: 10.7554/eLife.82037.
6
The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings.类风湿关节炎中单核细胞向破骨细胞的转化:最新发现。
Front Immunol. 2022 Sep 12;13:998554. doi: 10.3389/fimmu.2022.998554. eCollection 2022.
7
Intestinal Inflammation Promotes MDL-1 Osteoclast Precursor Expansion to Trigger Osteoclastogenesis and Bone Loss.肠道炎症促进 MDL-1 破骨细胞前体扩增,触发破骨细胞生成和骨丢失。
Cell Mol Gastroenterol Hepatol. 2022;14(4):731-750. doi: 10.1016/j.jcmgh.2022.07.002. Epub 2022 Jul 12.
8
The Effect of Anti-rheumatic Drugs on the Skeleton.抗风湿药物对骨骼的影响。
Calcif Tissue Int. 2022 Nov;111(5):445-456. doi: 10.1007/s00223-022-01001-y. Epub 2022 Jun 30.
9
Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions.类风湿关节炎关节破坏的机制——免疫细胞-成纤维细胞-骨相互作用。
Nat Rev Rheumatol. 2022 Jul;18(7):415-429. doi: 10.1038/s41584-022-00793-5. Epub 2022 Jun 15.
10
Effects of on Osteoclast Formation and Osteoblast Differentiation and on an OVX-Induced Bone Loss Model.对破骨细胞形成和成骨细胞分化以及对去卵巢诱导的骨丢失模型的影响。
Front Pharmacol. 2022 Jan 4;12:797892. doi: 10.3389/fphar.2021.797892. eCollection 2021.